Carlo Torti
Overview
Explore the profile of Carlo Torti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
269
Citations
3204
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Salvo P, Lombardi F, Sanfilippo A, Iannone V, Baldin G, Borghetti A, et al.
Travel Med Infect Dis
. 2025 Mar;
:102832.
PMID: 40068726
Background: Global warming has facilitated the spread of mosquito-borne diseases, including dengue, to non-endemic areas like Italy. People living with HIV (PLWH) are at increased risk of severe dengue, especially...
2.
Chiuchiarelli M, Micheli G, Segala F, Giuliano G, Del Giacomo P, Dusina A, et al.
J Neurovirol
. 2025 Feb;
PMID: 39971875
Progressive Multifocal Leukoencephalopathy (PML) is a rare opportunistic infection of the central nervous system (CNS) caused by human polyomavirus JC virus, with high mortality rate in people living with HIV...
3.
Rotundo S, Nistico S, Morrone H, Gallo L, Dodaro S, Papola C, et al.
J Clin Tuberc Other Mycobact Dis
. 2025 Feb;
38:100512.
PMID: 39949587
Tuberculosis (TB) remains a significant global health challenge, with the World Health Organization (WHO) aiming for a 95% reduction in TB deaths by 2030. Disparities in TB detection persist, particularly...
4.
Baldin G, Salvo P, Passerotto R, Iannone V, Lamanna F, Carbone A, et al.
AIDS
. 2025 Feb;
PMID: 39945629
Objectives: Results from clinical trials and observational studies suggest that dolutegravir plus lamivudine is a well tolerated option for simplification in people with HIV (PWH). We aimed to assess long-time...
5.
Salvo P, Ciccullo A, Visconti E, Lombardi F, Torti C, Di Giambenedetto S, et al.
HIV Med
. 2025 Feb;
PMID: 39907097
Objectives: This study aimed to evaluate the HIV virological efficacy of two-drug regimens (2DR) with lamivudine (3TC) and dolutegravir (DTG) in people with HIV (PWH), classified by their hepatitis B...
6.
Guerriero S, Matteini E, Gross M, Gavi F, Tamburrini E, Murri R, et al.
Expert Opin Pharmacother
. 2025 Jan;
26(2):167-177.
PMID: 39773267
Introduction: Complicated urinary tract infections (cUTIs) represent a significant clinical challenge due to their association with sepsis, high morbidity and mortality, and an increased risk of recurrence and chronic infection....
7.
Salmanton-Garcia J, Guerra Maio A, Stahl J, de Barra E, Jensen-Fangel S, Torti C, et al.
Clin Microbiol Infect
. 2024 Dec;
PMID: 39725078
Objectives: The objectives were to determine the structure of training programmes and assessment of physicians training to become infectious disease (ID) specialists in Europe in early 2024 and to document...
8.
Spartano S, Faggiano M, Guidi G, DAmbrosio P, Vaisfeld A, Novelli A, et al.
Int J Mol Sci
. 2024 Dec;
25(23).
PMID: 39684907
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection, responsible for Coronavirus Disease 2019 (COVID-19), exhibits a spectrum of clinical manifestations, ranging from asymptomatic to severe pulmonary dysfunction or death. The...
9.
Sangiorgi F, Magrini E, Leanza G, Catania F, Carbone A, Losito A, et al.
Diagn Microbiol Infect Dis
. 2024 Nov;
111(1):116583.
PMID: 39514950
Tuberculous lymphadenitis is one of the most common extrapulmonary manifestation of tuberculosis. Lymphadenitis due to Listeria monocytogenes is rarely described. We present a case of a 59-year-old woman from Mexico...
10.
Leanza G, Rando E, Frondizi F, Taddei E, Giovannenze F, Horcajada J, et al.
Infection
. 2024 Sep;
53(1):15-23.
PMID: 39325353
Introduction: Dalbavancin is an antibiotic characterized by an extended half-life and efficacy against methicillin-resistant Staphylococci. Currently, there are only narrative reviews summarizing the evidence about the use of dalbavancin for...